Skip to main content
Top
Published in: Systematic Reviews 1/2021

Open Access 01-12-2021 | Diabetic Retinopathy | Protocol

Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol

Authors: Covadonga Bascaran, Nyawira Mwangi, Fabrizio D’Esposito, Charles Cleland, Iris Gordon, Juan Alberto Lopez Ulloa, Ranad Maswadi, Shaffi Mdala, Jacqueline Ramke, Jennifer R. Evans, Matthew Burton

Published in: Systematic Reviews | Issue 1/2021

Login to get access

Abstract

Background

Vision loss due to diabetic retinopathy can largely be prevented or delayed through treatment. Patients with vision-threatening diabetic retinopathy are typically offered laser or intravitreal injections which often require more than one treatment cycle. However, treatment is not always initiated, or it is not completed, resulting in poor visual outcomes. Interventions aimed at improving the uptake or completion of treatment for diabetic retinopathy can potentially help prevent or delay visual loss in people with diabetes.

Methods

We will search MEDLINE, Embase, Global Health and Cochrane Register of Studies for studies reporting interventions to improve the uptake of treatment for diabetic retinopathy (DR) and/or diabetic macular oedema (DMO), compared with usual care, in adults with diabetes. The review will include studies published in the last 20 years in the English language. We will include any study design that measured any of the following outcomes in relation to treatment uptake and completion for DR and/or DMO: (1) proportion of patients initiating treatment for DR and/or DMO among those to whom it is recommended, (2) proportion of patients completing treatment for DR and/or DMO among those to whom it is recommended, (3) proportion of patients completing treatment for DR and/or DMO among those initiating treatment and (4) number and proportion of DR and/or DMO rounds of treatment completed per patient, as dictated by the treatment protocol. For included studies, we will also report any measures of cost-effectiveness when available. Two reviewers will screen search results independently. Risk of bias assessment will be done by two reviewers, and data extraction will be done by one reviewer with verification of 10% of the papers by a second reviewer. The results will be synthesised narratively.

Discussion

This rapid review aims to identify and synthesise the peer-reviewed literature on the effectiveness of interventions to increase uptake and completion of treatment for DR and/or DMO in LMICs. The rapid review methodology was chosen in order to rapidly synthesise the available evidence to support programme implementers and policy-makers in designing evidence-based health programmes and public health policy and inform the allocation of resources.

Systematic review registration

Appendix
Available only for authorised users
Literature
1.
go back to reference Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018 Oct;125(10):1608–22.CrossRef Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018 Oct;125(10):1608–22.CrossRef
2.
go back to reference Mwangi N. ea. Clinical guidelines for diabetic retinopathy in Kenya: an executive summary of the recommendations. JOECSA. 2017;21(2):33–9. Mwangi N. ea. Clinical guidelines for diabetic retinopathy in Kenya: an executive summary of the recommendations. JOECSA. 2017;21(2):33–9.
3.
go back to reference Jacobs B, Ir P, Bigdeli M, Annear PL, Van Damme W. Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy Plann. 2012;27(4):288–300.CrossRef Jacobs B, Ir P, Bigdeli M, Annear PL, Van Damme W. Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries. Health Policy Plann. 2012;27(4):288–300.CrossRef
4.
go back to reference Poore S, Foster A, Zondervan M, Blanchet K. Planning and developing services for diabetic retinopathy in sub-Saharan Africa. Int J Health Policy Manage. 2015;4(1):19–28.CrossRef Poore S, Foster A, Zondervan M, Blanchet K. Planning and developing services for diabetic retinopathy in sub-Saharan Africa. Int J Health Policy Manage. 2015;4(1):19–28.CrossRef
5.
go back to reference Burgess PI, Msukwa G, Beare NA. Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med. 2013;11:157.CrossRef Burgess PI, Msukwa G, Beare NA. Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med. 2013;11:157.CrossRef
7.
go back to reference Memon S, Ahsan S, Alvi R, Fawwad A, Basit A, Shera S, et al. Retinal screening acceptance, laser treatment uptake and follow-up response in diabetics requiring laser therapy in an urban diabetes care centre. J Coll Phys Surg Pak. 2015;25(10):743–6. Memon S, Ahsan S, Alvi R, Fawwad A, Basit A, Shera S, et al. Retinal screening acceptance, laser treatment uptake and follow-up response in diabetics requiring laser therapy in an urban diabetes care centre. J Coll Phys Surg Pak. 2015;25(10):743–6.
8.
go back to reference Khandekar R, Al Lawati J, Barakat N. A retrieval system for patients with avoidable blindness due to diabetic retinopathy who do not present for ophthalmic assessment in Oman. Middle East Afr J Ophthalmol. 2011;18(2):93–7.CrossRef Khandekar R, Al Lawati J, Barakat N. A retrieval system for patients with avoidable blindness due to diabetic retinopathy who do not present for ophthalmic assessment in Oman. Middle East Afr J Ophthalmol. 2011;18(2):93–7.CrossRef
9.
go back to reference Hua W, Cao S, Cui J, Maberley D, Matsubara J. Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy. Can J Ophthalmol. 2017;52(Suppl 1):S34–s8.CrossRef Hua W, Cao S, Cui J, Maberley D, Matsubara J. Analysis of reasons for noncompliance with laser treatment in patients of diabetic retinopathy. Can J Ophthalmol. 2017;52(Suppl 1):S34–s8.CrossRef
10.
go back to reference Will JC, German RR, Schuman E, Michael S, Kurth DM, Deeb L. Patient adherence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study. Am J Public Health. 1994;84(10):1669–71.CrossRef Will JC, German RR, Schuman E, Michael S, Kurth DM, Deeb L. Patient adherence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study. Am J Public Health. 1994;84(10):1669–71.CrossRef
11.
go back to reference Group TDRSR. Photocoagulation for diabetic macular edema. early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1985;103(12):1796–806.CrossRef Group TDRSR. Photocoagulation for diabetic macular edema. early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1985;103(12):1796–806.CrossRef
12.
go back to reference Jorge EC, Jorge EN, Botelho M, Farat JG, Virgili G, El Dib R. Monotherapy laser photocoagulation for diabetic macular oedema. Cochrane Database Syst Rev. 2018;10:Cd010859.PubMed Jorge EC, Jorge EN, Botelho M, Farat JG, Virgili G, El Dib R. Monotherapy laser photocoagulation for diabetic macular oedema. Cochrane Database Syst Rev. 2018;10:Cd010859.PubMed
13.
go back to reference Moutray T, Evans JR, Lois N, Armstrong DJ, Peto T, Azuara-Blanco A. Different lasers and techniques for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2018;3:Cd012314.PubMed Moutray T, Evans JR, Lois N, Armstrong DJ, Peto T, Azuara-Blanco A. Different lasers and techniques for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2018;3:Cd012314.PubMed
14.
go back to reference Martinez-Zapata MJ, Marti-Carvajal AJ, Sola I, Pijoan JI, Buil-Calvo JA, Cordero JA, et al. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014 Nov 24(11):Cd008721. Martinez-Zapata MJ, Marti-Carvajal AJ, Sola I, Pijoan JI, Buil-Calvo JA, Cordero JA, et al. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database Syst Rev. 2014 Nov 24(11):Cd008721.
15.
go back to reference Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2018;10:Cd007419.PubMed Virgili G, Parravano M, Evans JR, Gordon I, Lucenteforte E. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis. Cochrane Database Syst Rev. 2018;10:Cd007419.PubMed
16.
go back to reference Grover D, Li TJ, Chong CC. Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev. 2008;23(1):Cd005656. Grover D, Li TJ, Chong CC. Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev. 2008;23(1):Cd005656.
17.
go back to reference Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database Syst Rev. 2018;4:Cd011599.PubMed Mehta H, Hennings C, Gillies MC, Nguyen V, Campain A, Fraser-Bell S. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema. Cochrane Database Syst Rev. 2018;4:Cd011599.PubMed
18.
go back to reference Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3:Cd005139.PubMed Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3:Cd005139.PubMed
19.
go back to reference Angermann R, Rauchegger T, Nowosielski Y, Casazza M, Bilgeri A, Ulmer H, et al. Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2119–25.CrossRef Angermann R, Rauchegger T, Nowosielski Y, Casazza M, Bilgeri A, Ulmer H, et al. Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage. Graefes Arch Clin Exp Ophthalmol. 2019;257(10):2119–25.CrossRef
20.
go back to reference Jansen ME, Krambeer CJ, Kermany DS, Waters JN, Tie W, Bahadorani S, et al. Appointment compliance in patients with diabetic macular edema and exudative macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2018;49(3):186–90.CrossRef Jansen ME, Krambeer CJ, Kermany DS, Waters JN, Tie W, Bahadorani S, et al. Appointment compliance in patients with diabetic macular edema and exudative macular degeneration. Ophthalmic Surg Lasers Imaging Retina. 2018;49(3):186–90.CrossRef
21.
go back to reference Best AL, Fajnkuchen F, Nghiem-Buffet S, Grenet T, Quentel G, Delahaye-Mazza C, et al. Treatment efficacy and compliance in patients with diabetic macular edema treated with ranibizumab in a real-life setting. J Ophthalmol. 2018;2018:4610129.CrossRef Best AL, Fajnkuchen F, Nghiem-Buffet S, Grenet T, Quentel G, Delahaye-Mazza C, et al. Treatment efficacy and compliance in patients with diabetic macular edema treated with ranibizumab in a real-life setting. J Ophthalmol. 2018;2018:4610129.CrossRef
22.
go back to reference Spooner KL, Guinan G, Koller S, Hong T, Chang AA. Burden of treatment among patients undergoing intravitreal injections for diabetic macular oedema in Australia. Diab Metab Syndr Obes Targets Ther. 2019;12:1913–21.CrossRef Spooner KL, Guinan G, Koller S, Hong T, Chang AA. Burden of treatment among patients undergoing intravitreal injections for diabetic macular oedema in Australia. Diab Metab Syndr Obes Targets Ther. 2019;12:1913–21.CrossRef
23.
go back to reference Gohil R, Crosby-Nwaobi R, Forbes A, Burton B, Hykin P, Sivaprasad S. Caregiver burden in patients receiving ranibizumab therapy for neovascular age related macular degeneration. PloS one. 2015;10(6):e0129361.CrossRef Gohil R, Crosby-Nwaobi R, Forbes A, Burton B, Hykin P, Sivaprasad S. Caregiver burden in patients receiving ranibizumab therapy for neovascular age related macular degeneration. PloS one. 2015;10(6):e0129361.CrossRef
24.
go back to reference Hanemoto T, Hikichi Y, Kikuchi N, Kozawa T. The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting. PloS one. 2017;12(12):e0189035.CrossRef Hanemoto T, Hikichi Y, Kikuchi N, Kozawa T. The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting. PloS one. 2017;12(12):e0189035.CrossRef
25.
go back to reference Abdullah P, Eva K, Katherine C, Marrissa M-SJ, Ruth W. SelecTing Approaches for Rapid Reviews (STARR) Decision Tool 2019. Abdullah P, Eva K, Katherine C, Marrissa M-SJ, Ruth W. SelecTing Approaches for Rapid Reviews (STARR) Decision Tool 2019.
26.
go back to reference Andrea C. Tricco EVL, Sharon E. Straus. Rapid reviews to strengthen health policy and systems: a practical guide. In: WHO, editor. 2017. Andrea C. Tricco EVL, Sharon E. Straus. Rapid reviews to strengthen health policy and systems: a practical guide. In: WHO, editor. 2017.
27.
go back to reference Bascaran C, Mwangi N, D’Esposito F, Cleland CR, Ulloa JAL, Gordon I, Burton M. Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol. Retrieved from https://doi.org/10.17605/OSF.IO/H5WGR. Bascaran C, Mwangi N, D’Esposito F, Cleland CR, Ulloa JAL, Gordon I, Burton M. Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol. Retrieved from https://​doi.​org/​10.​17605/​OSF.​IO/​H5WGR.
28.
go back to reference Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890.CrossRef Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890.CrossRef
29.
go back to reference Murad MH, Mustafa RA, Schunemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evidence-based medicine. 2017 Jun;22(3):85–7.CrossRef Murad MH, Mustafa RA, Schunemann HJ, Sultan S, Santesso N. Rating the certainty in evidence in the absence of a single estimate of effect. Evidence-based medicine. 2017 Jun;22(3):85–7.CrossRef
Metadata
Title
Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol
Authors
Covadonga Bascaran
Nyawira Mwangi
Fabrizio D’Esposito
Charles Cleland
Iris Gordon
Juan Alberto Lopez Ulloa
Ranad Maswadi
Shaffi Mdala
Jacqueline Ramke
Jennifer R. Evans
Matthew Burton
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2021
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-020-01562-9

Other articles of this Issue 1/2021

Systematic Reviews 1/2021 Go to the issue